# Sildenafil Plus Hypothermia to Treat Neonatal Encephalopathy

> **NCT06810284** · PHASE2 · NOT_YET_RECRUITING · sponsor: **Assistance Publique - Hôpitaux de Paris** · enrollment: 24 (estimated)

## Conditions studied

- Hypoxic-Ischemic Encephalopathy

## Interventions

- **DRUG:** Sildenafil Citrate (IV)

## Key facts

- **NCT ID:** NCT06810284
- **Lead sponsor:** Assistance Publique - Hôpitaux de Paris
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-10
- **Primary completion:** 2027-06
- **Final completion:** 2029-05
- **Target enrollment:** 24 (ESTIMATED)
- **Last updated:** 2026-03-31

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06810284

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06810284, "Sildenafil Plus Hypothermia to Treat Neonatal Encephalopathy". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06810284. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*